AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
EBITDA Over TimeStrong
Percentile Rank100
3Y CAGR+6.7%
5Y CAGR+10.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+6.7%/yr
vs +11.2%/yr prior
5Y CAGR
+10.5%/yr
Recent deceleration
Acceleration
-4.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$12.68B+0.9%
2024$12.57B+42.6%
2023$8.81B-15.6%
2022$10.44B+2.0%
2021$10.24B+32.8%
2020$7.71B+31.2%
2019$5.88B-13.9%
2018$6.83B-4.0%
2017$7.11B+17.3%
2016$6.06B-